T‐bet and Eomes are key transcription factors for NK cell effector functions and antitumor immunity.[2, 3] To investigate the underlying mechanisms of action by Tipe2−/‐ NK cells in supporting the CD8+ T cell antitumor response, we analyzed the expression of T‐bet and Eomes in tumor‐infiltrating NK cells. Here, CD8A is linked to neoplasm.